Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duramesh Versus Minimally Invasive Intraperitoneal Onlay Mesh (IPOM) for High-Risk Umbilical Hernia Repairs: A Randomized Controlled Trial

NCT07881354 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT07881354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07881354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duramesh Versus Minimally Invasive Intraperitoneal Onlay Mesh (IPOM) for High-Risk Umbilical Hernia Repairs: A Randomized Controlled Trial
Lead sponsor
Northwestern University
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2026
Completion date
October 31, 2029
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

umbilical hernia, ventral hernia